0001127602-24-001286.txt : 20240112
0001127602-24-001286.hdr.sgml : 20240112
20240112172040
ACCESSION NUMBER: 0001127602-24-001286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240112
DATE AS OF CHANGE: 20240112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENDERSON JOHN T
CENTRAL INDEX KEY: 0001226488
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 24532905
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-01-12
0001061983
CYTOKINETICS INC
CYTK
0001226488
HENDERSON JOHN T
350 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
1
1
Common Stock
83
I
by Spouse
Common Stock
2024-01-12
4
M
0
5000
4.44
A
47632
D
Common Stock
2024-01-12
4
S
0
5000
85.14
D
42632
D
Non-Qualified Stock Option (Right to Buy)
4.44
2024-01-12
4
M
0
5000
0
D
2014-06-21
2024-05-21
Common Stock
5000
5000
D
Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.
/s/ John Faurescu, attorney-in-fact for Dr. Henderson
2024-01-12